Department of War (DoW) / independent acquisition review
Flight-readiness checklist 01
Record frozen
March 31, 2021
Decision / full production
The production-phase announcement is real. A scored operational comparison of production-representative IVAS against current equipment is not in this packet. Keep the full-rate gate conditional on that evidence, not on an expected shipment or a prototype exercise. [ST2] [ST1]
This is a judgment on the public record available by the cutoff, not a finding about later performance.
Switch the view to challenge the announcement against its closest public test evidence.
“Earlier today, the United States Army announced that it will work with Microsoft on the production phase of the Integrated Visual Augmentation System (IVAS) program as it moves from rapid prototyping to production and rapid fielding.”
The platform is claimed to make soldiers safer and more effective. The dated original [ST2] gives no monetary contract value, purchase count, or unlimited-purchase authorization.
STP 2 exercised prototypes in an operational environment. Conventional soldiers and marines favored perceived usefulness; special operators favored identification, translation, and reconnaissance but did not find most functions better than their current gear. GPS, imagery sensors, RTA integration, light discipline, fogging, extended-wear discomfort, and gear interoperability drew concern. [ST1]
DOT&E says the STP 2 plan was not submitted for approval because it was an experiment; comparative company force-on-force and squad live fire were planned, not scored findings. [ST1]
Receipt is not the same as a purchase count; scheduled receipt is not completed delivery.
BQ6 engineering development only. The comparison does not price the acquisition agreement. [ST3]
Bar width uses FY 2020 as the $63,200,000 denominator; FY 2021 Base is $8,991,000 / $63,200,000. Source: [ST3].
Comparable denominator: FY 2020 BQ6 development line. FY 2021 Base versus FY 2020, not agreement cost. The Army's budget excerpt attributes the change to transition from rapid prototyping to rapid fielding. [ST3]
Specify and approve thresholds before observing results. This packet supplies no official numeric pass marks. [ST1]
Authority. Obtain signed decision and acquisition scope, funded quantities, obligations and ceiling if one exists. Do not convert the development line into an agreement price. [ST2] [ST3]
Test article. Approve the test and evaluation strategy and fix the production-representative hardware, software, power, tactical gear and sustainment baseline. Verify closure of CS 2 integration defects before attributing prototype results to it. [ST1]
Combat comparison. Under a DOT&E-accepted plan, score company force-on-force and squad live fire versus current equipment. Pre-register mission outcomes and confidence bounds; require net advantage with uncertainty excluding no benefit and no mission-critical regression. [ST1]
Suitability and safety. Pre-set pass/fail limits for accuracy, RTA reliability, light emission, fogging, wear duration, interoperability and cold, heat and humidity. Record adverse events and exposure denominators with a medical stop rule; no injury rate can be estimated here. [ST1] [ST7]
Full-rate decision. Review scored comparative effectiveness, suitability, defect closure, safety, lifecycle affordability and approved quantity. The favorable response to some functions supports further testing, not a waiver of this gate. [ST1]
No verified agreement value or ceiling, unlimited-purchase authority, units purchased, paid cost, or lifecycle cost. The BQ6 development allocation is a different funding category. [ST2] [ST3]
No confirmed April 2021 delivery, production-representative scored comparison, results for an untested configuration, physiological injury incidence, or exposure denominator. The March 29 cold-weather story is a reported field exercise, not that comparison. [ST1] [ST7]